3Dbioprinteissä

3Dbioprinteissä is a Finnish company specializing in 3D bioprinting technology. Founded with the goal of advancing regenerative medicine and tissue engineering, the company develops and offers bioprinting solutions for research and clinical applications. Their work focuses on creating functional biological constructs, such as tissues and organs, by precisely depositing living cells and biomaterials in a layer-by-layer fashion.

The technology employed by 3Dbioprinteissä utilizes advanced bio-inks, which are formulations containing cells and biocompatible materials designed to support cell viability and function during and after the printing process. These bio-inks are then guided by specialized 3D bioprinting equipment to construct intricate biological architectures that mimic native tissues. The company's research and development efforts are directed towards improving the resolution, speed, and scalability of bioprinting, as well as expanding the range of cell types and biomaterials that can be utilized.

3Dbioprinteissä aims to address critical challenges in healthcare, including organ shortages for transplantation and the need for more effective drug testing models. By enabling the creation of patient-specific tissues, their technology holds potential for personalized medicine, reducing immune rejection and improving treatment outcomes. The company collaborates with research institutions and pharmaceutical companies to further develop and validate their bioprinting platforms for various applications, contributing to the global advancement of bioprinting science.